Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Regeneron Pharmaceuticals Inc recalls Libtayo (cemiplimab-rwlc) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Libtayo (cemiplimab-rwlc) Injection
Where it was sold

USA Nationwide

Nationwide

Units affected
21,353 vials
About this recall
Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; Marketed by: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY 10591), NDC 61755-008-01